Conference Reports for NATAP

IAS 2023 July 23rd - 26th 12th IAS Conference on HIV Science Back

The REPRIEVE trial: Developing a cardiovascular disease prevention strategy for people living with HIV - "should be inserted in Guidelines"       IAS 2023 july 24   REPRIEVE Results published: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection - (07/24/23)